221 related articles for article (PubMed ID: 33107698)
21. Curcumin and obesity: evidence and mechanisms.
Alappat L; Awad AB
Nutr Rev; 2010 Dec; 68(12):729-38. PubMed ID: 21091916
[TBL] [Abstract][Full Text] [Related]
22. Molecular Mechanisms Underlying Curcumin-Mediated Therapeutic Effects in Type 2 Diabetes and Cancer.
Wojcik M; Krawczyk M; Wojcik P; Cypryk K; Wozniak LA
Oxid Med Cell Longev; 2018; 2018():9698258. PubMed ID: 29743988
[TBL] [Abstract][Full Text] [Related]
23. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
24. An overview of the therapeutic effects of curcumin in reproductive disorders with a focus on the antiinflammatory and immunomodulatory activities.
Saifi B; Haftcheshmeh SM; Feligioni M; Izadpanah E; Rahimi K; Hassanzadeh K; Mohammadi A; Sahebkar A
Phytother Res; 2022 Feb; 36(2):808-823. PubMed ID: 35041229
[TBL] [Abstract][Full Text] [Related]
25. Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications.
Meng B; Li J; Cao H
Curr Pharm Des; 2013; 19(11):2101-13. PubMed ID: 23116316
[TBL] [Abstract][Full Text] [Related]
26. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats.
Sajithlal GB; Chithra P; Chandrakasan G
Biochem Pharmacol; 1998 Dec; 56(12):1607-14. PubMed ID: 9973181
[TBL] [Abstract][Full Text] [Related]
27. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.
Baum L; Lam CW; Cheung SK; Kwok T; Lui V; Tsoh J; Lam L; Leung V; Hui E; Ng C; Woo J; Chiu HF; Goggins WB; Zee BC; Cheng KF; Fong CY; Wong A; Mok H; Chow MS; Ho PC; Ip SP; Ho CS; Yu XW; Lai CY; Chan MH; Szeto S; Chan IH; Mok V
J Clin Psychopharmacol; 2008 Feb; 28(1):110-3. PubMed ID: 18204357
[No Abstract] [Full Text] [Related]
28. Mitochondria as a target in the therapeutic properties of curcumin.
Trujillo J; Granados-Castro LF; Zazueta C; Andérica-Romero AC; Chirino YI; Pedraza-Chaverrí J
Arch Pharm (Weinheim); 2014 Dec; 347(12):873-84. PubMed ID: 25243820
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic impact of curcumin on stroke prevention.
Kalani A; Kamat PK; Kalani K; Tyagi N
Metab Brain Dis; 2015 Apr; 30(2):427-35. PubMed ID: 24788895
[TBL] [Abstract][Full Text] [Related]
30. Ameliorating potential of curcumin and its analogue in central nervous system disorders and related conditions: A review of molecular pathways.
Joshi P; Bisht A; Joshi S; Semwal D; Nema NK; Dwivedi J; Sharma S
Phytother Res; 2022 Aug; 36(8):3143-3180. PubMed ID: 35790042
[TBL] [Abstract][Full Text] [Related]
31. Protective Effects of Curcumin Against Nephrotoxic Agents.
Farkhondeh T; Samarghandian S; Azimi-Nezhad M; Shahri AMP
Cardiovasc Hematol Disord Drug Targets; 2019; 19(3):176-182. PubMed ID: 30205807
[TBL] [Abstract][Full Text] [Related]
32. Herbal antioxidants in dialysis patients: a review of potential mechanisms and medical implications.
Asgharpour M; Alirezaei A
Ren Fail; 2021 Dec; 43(1):351-361. PubMed ID: 33593237
[TBL] [Abstract][Full Text] [Related]
33. The targets of curcumin.
Zhou H; Beevers CS; Huang S
Curr Drug Targets; 2011 Mar; 12(3):332-47. PubMed ID: 20955148
[TBL] [Abstract][Full Text] [Related]
34. A review of therapeutic effects of curcumin.
Noorafshan A; Ashkani-Esfahani S
Curr Pharm Des; 2013; 19(11):2032-46. PubMed ID: 23116311
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic potential of curcumin in major retinal pathologies.
Peddada KV; Brown A; Verma V; Nebbioso M
Int Ophthalmol; 2019 Mar; 39(3):725-734. PubMed ID: 29404861
[TBL] [Abstract][Full Text] [Related]
36. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
37. Curcumin attenuates oxidative stress induced NFκB mediated inflammation and endoplasmic reticulum dependent apoptosis of splenocytes in diabetes.
Rashid K; Chowdhury S; Ghosh S; Sil PC
Biochem Pharmacol; 2017 Nov; 143():140-155. PubMed ID: 28711624
[TBL] [Abstract][Full Text] [Related]
38. Formulations of Curcumin Nanoparticles for Brain Diseases.
Del Prado-Audelo ML; Caballero-Florán IH; Meza-Toledo JA; Mendoza-Muñoz N; González-Torres M; Florán B; Cortés H; Leyva-Gómez G
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30743984
[TBL] [Abstract][Full Text] [Related]
39. Curcumin and liver cancer: a review.
Darvesh AS; Aggarwal BB; Bishayee A
Curr Pharm Biotechnol; 2012 Jan; 13(1):218-28. PubMed ID: 21466422
[TBL] [Abstract][Full Text] [Related]
40. Curcumin, inflammation, and chronic diseases: how are they linked?
He Y; Yue Y; Zheng X; Zhang K; Chen S; Du Z
Molecules; 2015 May; 20(5):9183-213. PubMed ID: 26007179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
